相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。FK866-induced NAMPT inhibition activates AMPK and downregulates mTOR signaling in hepatocarcinoma cells
Susanne Schuster et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
SIRT1-Mediated eNAMPT Secretion from Adipose Tissue Regulates Hypothalamic NAD+ and Function in Mice
Myeong Jin Yoon et al.
CELL METABOLISM (2015)
Extracellular nicotinamide phosphoribosyltransferase (NAMPT) promotes M2 macrophage polarization in chronic lymphocytic leukemia
Valentina Audrito et al.
BLOOD (2015)
NAD Biosynthesis in Humans - Enzymes, Metabolites and Therapeutic Aspects
Christian Dölle et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2015)
Increasing NAD Synthesis in Muscle via Nicotinamide Phosphoribosyltransferase Is Not Sufficient to Promote Oxidative Metabolism
David W. Frederick et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Troxerutin improves hepatic lipid homeostasis by restoring NAD+-depletion-mediated dysfunction of lipin 1 signaling in high-fat diet-treated mice
Zi-Feng Zhang et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Inhibition of De Novo NAD+ Synthesis by Oncogenic URI Causes Liver Tumorigenesis through DNA Damage
Krishna S. Tummala et al.
CANCER CELL (2014)
Synergy between the NAMPT Inhibitor GMX1777(8) and Pemetrexed in Non-Small Cell Lung Cancer Cells Is Mediated by PARP Activation and Enhanced NAD Consumption
Manuel Chan et al.
CANCER RESEARCH (2014)
On-Target Effect of FK866, a Nicotinamide Phosphoribosyl Transferase Inhibitor, by Apoptosis-Mediated Death in Chronic Lymphocytic Leukemia Cells
Iris Gehrke et al.
CLINICAL CANCER RESEARCH (2014)
Blockade of visfatin induction by oleanolic acid via disturbing IL-6-TRAF6-NF-κB signaling of adipocytes
Hyun-Sung Kim et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2014)
Novel assay for simultaneous measurement of pyridine mononucleotides synthesizing activities allows dissection of the NAD+ biosynthetic machinery in mammalian cells
Federica Zamporlini et al.
FEBS JOURNAL (2014)
Visfatin-948G/T and resistin-420C/G polymorphisms in Egyptian type 2 diabetic patients with and without cardiovascular diseases
Tarek M. K. Motawi et al.
GENOME (2014)
Extracellular Visfatin Activates Gluconeogenesis in HepG2 Cells Through the Classical PKA/CREB-Dependent Pathway
Y. J. Choi et al.
HORMONE AND METABOLIC RESEARCH (2014)
Visfatin/Nampt induces telomere damage and senescence in human endothelial cells
Laura A. Villalobos et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2014)
Nicotinamide Phosphoribosyltransferase Promotes Epithelial-to-Mesenchymal Transition as a Soluble Factor Independent of Its Enzymatic Activity
Debora Soncini et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Neuronal NAMPT is released after cerebral ischemia and protects against white matter injury
Zheng Jing et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2014)
Nicotinamide improves glucose metabolism and affects the hepatic NAD-sirtuin pathway in a rodent model of obesity and type 2 diabetes
Soo Jin Yang et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2014)
Nicotinamide Phosphoribosyltransferase Is Required for the Calorie Restriction-Mediated Improvements in Oxidative Stress, Mitochondrial Biogenesis, and Metabolic Adaptation
Jie Song et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2014)
Relationship between circulating visfatin/NAMPT, nutritional status and insulin resistance in an elderly population - results from the PolSenior substudy
Magdalena Olszanecka-Glinianowicz et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2014)
Resveratrol Differentially Regulates NAMPT and SIRT1 in Hepatocarcinoma Cells and Primary Human Hepatocytes
Susanne Schuster et al.
PLOS ONE (2014)
Mechanism of Inhibition of the Human Sirtuin Enzyme SIRT3 by Nicotinamide: Computational and Experimental Studies
Xiangying Guan et al.
PLOS ONE (2014)
Metabolic Profiling of Alternative NAD Biosynthetic Routes in Mouse Tissues
Valerio Mori et al.
PLOS ONE (2014)
NAD+ and sirtuins in aging and disease
Shin-ichiro Imai et al.
TRENDS IN CELL BIOLOGY (2014)
SIRT1 and other sirtuins in metabolism
Hung-Chun Chang et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2014)
Genetic variants in NAMPT predict bladder cancer risk and prognosis in individuals from southwest Chinese Han group
Kui Zhang et al.
TUMOR BIOLOGY (2014)
Visfatin promotes cell and tumor growth by upregulating Notch1 in breast cancer
Hyun-Joo Park et al.
ONCOTARGET (2014)
Expression of Nicotinamide Phosphoribosyltransferase-Influenced Genes Predicts Recurrence-Free Survival in Lung and Breast Cancers
Tong Zhou et al.
SCIENTIFIC REPORTS (2014)
Adipokines - removing road blocks to obesity and diabetes therapy
Matthias Blueher
MOLECULAR METABOLISM (2014)
Mechanism linking diabetes mellitus and obesity
Abdullah S. Al-Goblan et al.
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2014)
Elevated microRNA-34a in obesity reduces NAD+ levels and SIRT1 activity by directly targeting NAMPT
Sung-E Choi et al.
AGING CELL (2013)
Nampt secreted from cardiomyocytes promotes development of cardiac hypertrophy and adverse ventricular remodeling
Vinodkumar B. Pillai et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2013)
Association of adipokines with obesity in children and adolescents
Anila Jaleel et al.
BIOMARKERS IN MEDICINE (2013)
Association of circulating levels of nicotinamide phosphoribosyltransferase (NAMPT/Visfatin) and of a frequent polymorphism in the promoter of the NAMPT gene with coronary artery disease in diabetic and non-diabetic subjects
Pedro Saddi-Rosa et al.
CARDIOVASCULAR DIABETOLOGY (2013)
Plasma visfatin levels and gene expression in morbidly obese women with associated fatty liver disease
Teresa Auguet et al.
CLINICAL BIOCHEMISTRY (2013)
NAD+ metabolism: A therapeutic target for age-related metabolic disease
Laurent Mouchiroud et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2013)
A role of intracellular mono-ADP-ribosylation in cancer biology
Emanuele S. Scarpa et al.
FEBS JOURNAL (2013)
Seminal plasma adipokine levels are correlated with functional characteristics of spermatozoa
Stephanie Thomas et al.
FERTILITY AND STERILITY (2013)
Visfatin, a potential biomarker and prognostic factor for endometrial cancer
Wenyan Tian et al.
GYNECOLOGIC ONCOLOGY (2013)
Involvement of p53 in the cytotoxic activity of the NAMPT inhibitor FK866 in myeloid leukemic cells
Basant Kumar Thakur et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Pharmacological Inhibition of Nicotinamide Phosphoribosyltransferase (NAMPT), an Enzyme Essential for NAD+ Biosynthesis, in Human Cancer Cells METABOLIC BASIS AND POTENTIAL CLINICAL IMPLICATIONS
Bo Tan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
CD73 Protein as a Source of Extracellular Precursors for Sustained NAD+ Biosynthesis in FK866-treated Tumor Cells
Alessia Grozio et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease
Rui E. Castro et al.
JOURNAL OF HEPATOLOGY (2013)
Nicotinamide Phosphoribosyltransferase Inhibitors, Design, Preparation, and Structure-Activity Relationship
Mette K. Christensen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Medicinal Chemistry of Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors
Ubaldina Galli et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Recycling Nicotinamide. The Transition-State Structure of Human Nicotinamide Phosphoribosyltransferase
Emmanuel S. Burgos et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2013)
Poly(ADP-ribose): PARadigms and PARadoxes
Alexander Buerkle et al.
MOLECULAR ASPECTS OF MEDICINE (2013)
Visfatin/Nampt: An Adipokine with Cardiovascular Impact
Tania Romacho et al.
MEDIATORS OF INFLAMMATION (2013)
Effect of Weight Reduction Following Bariatric Surgery on Serum Visfatin and Adiponectin Levels in Morbidly Obese Subjects
Mohammad Javad Hosseinzadeh-Attar et al.
OBESITY FACTS (2013)
Expression and Regulation of Nampt in Human Islets
Karen Kover et al.
PLOS ONE (2013)
The Adipocytokine Nampt and Its Product NMN Have No Effect on Beta-Cell Survival but Potentiate Glucose Stimulated Insulin Secretion
Robert Spinnler et al.
PLOS ONE (2013)
Shift Work or Food Intake during the Rest Phase Promotes Metabolic Disruption and Desynchrony of Liver Genes in Male Rats
Roberto C. Salgado-Delgado et al.
PLOS ONE (2013)
Ox-LDL Induces ER Stress and Promotes the adipokines Secretion in 3T3-L1 Adipocytes
Yaqin Chen et al.
PLOS ONE (2013)
Cerebral Ischemia Is Exacerbated by Extracellular Nicotinamide Phosphoribosyltransferase via a Non-Enzymatic Mechanism
Bing Zhao et al.
PLOS ONE (2013)
What about non-alcoholic fatty liver disease as a new criterion to define metabolic syndrome?
Giovanni Tarantino et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Age-related cognitive decline: Can neural stem cells help us?
Benedetta Artegiani et al.
AGING-US (2012)
Leucine supplementation increases SIRT1 expression and prevents mitochondrial dysfunction and metabolic disorders in high-fat diet-induced obese mice
Hongliang Li et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2012)
The high-resolution crystal structure of periplasmic Haemophilus influenzae NAD nucleotidase reveals a novel enzymatic function of human CD73 related to NAD metabolism
Silvia Garavaglia et al.
BIOCHEMICAL JOURNAL (2012)
Targeting NAD+ salvage pathway induces autophagy in multiple myeloma cells via mTORC1 and extracellular signal-regulated kinase (ERK1/2) inhibition
Michele Cea et al.
BLOOD (2012)
The NAD+ Precursor Nicotinamide Riboside Enhances Oxidative Metabolism and Protects against High-Fat Diet-Induced Obesity
Caries Canto et al.
CELL METABOLISM (2012)
Increased levels and adipose tissue expression of visfatin in morbidly obese women: the relationship with pro-inflammatory cytokines
Ximena Terra et al.
CLINICAL ENDOCRINOLOGY (2012)
On PAR with PARP: cellular stress signaling through poly(ADP-ribose) and PARP-1
Xin Luo et al.
GENES & DEVELOPMENT (2012)
Extracellular ATP induces P2X7-dependent nicotinamide phosphoribosyltransferase release in LPS-activated human monocytes
Erik Schilling et al.
INNATE IMMUNITY (2012)
Diurnal Rhythm of Circulating Nicotinamide Phosphoribosyltransferase (Nampt/Visfatin/PBEF): Impact of Sleep Loss and Relation to Glucose Metabolism
Christian Benedict et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Adipocytes as a Source of Increased Circulating Levels of Nicotinamide Phosphoribosyltransferase/Visfatin in Active Acromegaly
Nicoleta C. Olarescu et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Visfatin Levels in Nonalcoholic Fatty Liver Disease
Erdem Akbal et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2012)
Circadian Desynchrony Promotes Metabolic Disruption in a Mouse Model of Shiftwork
Johanna L. Barclay et al.
PLOS ONE (2012)
Monocytes Contribute to Differential Immune Pressure on R5 versus X4 HIV through the Adipocytokine Visfatin/NAMPT
Rafael Van den Bergh et al.
PLOS ONE (2012)
Nicotinamide Phosphoribosyl Transferase (Nampt) Is Required for De Novo Lipogenesis in Tumor Cells
Sarah C. Bowlby et al.
PLOS ONE (2012)
Serum Visfatin Levels, Adiposity and Glucose Metabolism in Obese Adolescents
Derya Taskesen et al.
JOURNAL OF CLINICAL RESEARCH IN PEDIATRIC ENDOCRINOLOGY (2012)
The NAD metabolome - a key determinant of cancer cell biology
Alberto Chiarugi et al.
NATURE REVIEWS CANCER (2012)
Possible Role of Visfatin in Hepatoma Progression and the Effects of Branched-Chain Amino Acids on Visfatin-Induced Proliferation in Human Hepatoma Cells
Soranobu Ninomiya et al.
CANCER PREVENTION RESEARCH (2011)
Nicotinamide Mononucleotide, a Key NAD+ Intermediate, Treats the Pathophysiology of Diet- and Age-Induced Diabetes in Mice
Jun Yoshino et al.
CELL METABOLISM (2011)
Visfatin in overweight/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome and cardiovascular diseases: a meta-analysis and systemic review
Yu-Hung Chang et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2011)
Nicotinamide mononucleotide protects against pro-inflammatory cytokine-mediated impairment of mouse islet function
P. W. Caton et al.
DIABETOLOGIA (2011)
Leucocytes are a major source of circulating nicotinamide phosphoribosyltransferase (NAMPT)/pre-B cell colony (PBEF)/visfatin linking obesity and inflammation in humans
D. Friebe et al.
DIABETOLOGIA (2011)
Visfatin in juvenile obesity - the effect of obesity intervention and sex
Malgorzata Krzystek-Korpacka et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2011)
Serum visfatin and vaspin levels in prepubertal children: effect of obesity and weight loss after behavior modifications on their secretion and relationship with glucose metabolism
G. A. Martos-Moreno et al.
INTERNATIONAL JOURNAL OF OBESITY (2011)
Hepatic FoxOs Regulate Lipid Metabolism via Modulation of Expression of the Nicotinamide Phosphoribosyltransferase Gene
Rongya Tao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Pathways and Subcellular Compartmentation of NAD Biosynthesis in Human Cells FROM ENTRY OF EXTRACELLULAR PRECURSORS TO MITOCHONDRIAL NAD GENERATION
Andrey Nikiforov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Involvement of visfatin in palmitate-induced upregulation of inflammatory cytokines in hepatocytes
Yong Jun Choi et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2011)
Vaspin and visfatin/Nampt are interesting interrelated adipokines playing a role in the pathogenesis of type 2 diabetes mellitus
Hala O. El-Mesallamy et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2011)
Visfatin induces neurite outgrowth in PC12 cells via ERK1/2 signaling pathway
Young-Soon Kang et al.
NEUROSCIENCE LETTERS (2011)
Impact of Metabolic Regulators on the Expression of the Obesity Associated Genes FTO and NAMPT in Human Preadipocytes and Adipocytes
Daniela Friebe et al.
PLOS ONE (2011)
Nicotinamide Phosphoribosyltransferase/Visfatin Does Not Catalyze Nicotinamide Mononucleotide Formation in Blood Plasma
Nobumasa Hara et al.
PLOS ONE (2011)
Skeletal muscle NAMPT is induced by exercise in humans
Sheila R. Costford et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2010)
Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin) is constitutively released from human hepatocytes
A. Garten et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Target enzyme mutations are the molecular basis for resistance towards pharmacological inhibition of nicotinamide phosphoribosyltransferase
Uffe H. Olesen et al.
BMC CANCER (2010)
Safety and efficacy of NAD depleting cancer drugs: results of a phase I clinical trial of CHS 828 and overview of published data
Anne von Heideman et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2010)
Pre-B Cell Colony Enhancing Factor/NAMPT/Visfatin in Inflammation and Obesity- Related Disorders
Alexander R. Moschen et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
Genetic variation in the visfatin (PBEF1/NAMPT) gene and type 2 diabetes in the Greek population
Peristera Paschou et al.
CYTOKINE (2010)
Body fat distribution has no effect on serum visfatin levels in healthy female subjects
Canan Ersoy et al.
CYTOKINE (2010)
Visfatin regulates genes related to lipid metabolism in porcine adipocytes
C. C. Yang et al.
JOURNAL OF ANIMAL SCIENCE (2010)
Inhibition of Nicotinamide Phosphoribosyltransferase CELLULAR BIOENERGETICS REVEALS A MITOCHONDRIAL INSENSITIVE NAD POOL
Maria Pittelli et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Intracellular Nicotinamide Phosphoribosyltransferase Protects against Hepatocyte Apoptosis and Is Down-Regulated in Nonalcoholic Fatty Liver Disease
Tuva B. Dahl et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Deleted in breast cancer-1 regulates SIRT1 activity and contributes to high-fat diet-induced liver steatosis in mice
Carlos Escande et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Exercise alters SIRT1, SIRT6, NAD and NAMPT levels in skeletal muscle of aged rats
Erika Koltai et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2010)
Visfatin Is a Positive Regulator of MCP-1 in Human Adipocytes In Vitro and in Mice In Vivo
Grit Sommer et al.
OBESITY (2010)
Expression of Neuropeptide Y, Omentin and Visfatin in Visceral and Subcutaneous Adipose Tissues in Humans: Relation to Endocrine and Clinical Parameters
Stephanie Barth et al.
OBESITY FACTS (2010)
Upregulation of fibroblast growth factor-2 by visfatin that promotes endothelial angiogenesis
Yun-Hee Bae et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Detection and pharmacological modulation of nicotinamide mononucleotide (NMN) in vitro and in vivo
Laura Formentini et al.
BIOCHEMICAL PHARMACOLOGY (2009)
APO866 activity in hematologic malignancies: a preclinical in vitro study
Michele Cea et al.
BLOOD (2009)
The NAD biosynthesis inhibitor APO866 has potent antitumor activity against hematologic malignancies
Aimable Nahimana et al.
BLOOD (2009)
Relationship Between Cerebrospinal Fluid Visfatin (PBEF/Nampt) Levels and Adiposity in Humans
Manfred Hallschmid et al.
DIABETES (2009)
Extracellular PBEF/NAMPT/visfatin activates pro-inflammatory signalling in human vascular smooth muscle cells through nicotinamide phosphoribosyltransferase activity
T. Romacho et al.
DIABETOLOGIA (2009)
Influence of Visfatin on Histopathological Changes of Non-alcoholic Fatty Liver Disease
R. Aller et al.
DIGESTIVE DISEASES AND SCIENCES (2009)
Therapeutic potential of SIRT1 and NAMPT-mediated NAD biosynthesis in type 2 diabetes
Shin-ichiro Imai et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2009)
Crystal structure of Rattus norvegicus Visfatin/PBEF/Nampt in complex with an FK866-based inhibitor
Gil Bu Kang et al.
MOLECULES AND CELLS (2009)
Intracellular NAD levels regulate tumor necrosis factor protein synthesis in a sirtuin-dependent manner
Frederic Van Gool et al.
NATURE MEDICINE (2009)
A Rare Variant in the Visfatin Gene (NAMPT/PBEF1) Is Associated With Protection From Obesity
Alexandra I. F. Blakemore et al.
OBESITY (2009)
Catastrophic NAD+ Depletion in Activated T Lymphocytes through Nampt Inhibition Reduces Demyelination and Disability in EAE
Santina Bruzzone et al.
PLOS ONE (2009)
Circadian Control of the NAD+ Salvage Pathway by CLOCK-SIRT1
Yasukazu Nakahata et al.
SCIENCE (2009)
Circadian Clock Feedback Cycle Through NAMPT-Mediated NAD(+) Biosynthesis
Kathryn Moynihan Ramsey et al.
SCIENCE (2009)
Nampt: linking NAD biology, metabolism and cancer
Antje Garten et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2009)
Role of adipocytokines in predicting the development of diabetes and its late complications
Nese Ersoz Gulcelik et al.
ENDOCRINE (2009)
Age-associated loss of Sirt1-mediated enhancement of glucose-stimulated insulin secretion in beta cell-specific Sirt1-overexpressing (BESTO) mice
Kathryn Moynihan Ramsey et al.
AGING CELL (2008)
Central visfatin causes orexigenic effects in chicks
Mark A. Cline et al.
BEHAVIOURAL BRAIN RESEARCH (2008)
Anticancer agent CHS-828 inhibits cellular synthesis of NAD
Uffe Hogh Olesen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Weak coupling of ATP hydrolysis to the chemical equilibrium of human nicotinamide phosphoribosyltransferase
Emmanuel S. Burgos et al.
BIOCHEMISTRY (2008)
PBEF1/NAmPRTase/Visfatin - A potential malignant astrocytoma/glioblastoma serum marker with prognostic value
P. Sreekanth Reddy et al.
CANCER BIOLOGY & THERAPY (2008)
Extracellular Nampt Promotes Macrophage Survival via a Nonenzymatic Interleukin-6/STAT3 Signaling Mechanism
Yankun Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Endothelial dysfunction in type-2 diabetics with early diabetic nephropathy is associated with low circulating adiponectin
Mahmut Ilker Yilmaz et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2008)
Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis
Raghu Adya et al.
CARDIOVASCULAR RESEARCH (2008)
The pharmacokinetics, toxicities, and biologic effects of FK866, a nicotinamide adenine dinucleotide biosynthesis inhibitor
Kyle Holen et al.
INVESTIGATIONAL NEW DRUGS (2008)
Metabolic adaptations through the PGC-1α and SIRT1 pathways
Joseph T. Rodgers et al.
FEBS LETTERS (2008)
Visfatin: a new player in mesangial cell physiology and diabetic nephropathy
Hye Kyoung Song et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2008)
Molecular characteristics of serum visfatin and differential detection by immunoassays
Antje Koerner et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Nampt/PBEF/Visfatin regulates insulin secretion in β cells as a systemic NAD biosynthetic enzyme
Javier R. Revollo et al.
CELL METABOLISM (2007)
Nutrient-sensitive mitochondrial NAD+ levels dictate cell survival
Hongying Yang et al.
CELL (2007)
TNF-α suppresses the expression of clock genes by interfering with E-box-mediated transcription
Gionata Cavadini et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Visfatin is released from 3T3-L1 adipocytes via a non-classical pathway
Masaki Tanaka et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Effects of genetic variation in the visfatin gene (PBEF1) on obesity, glucose metabolism, and blood pressure in children
Antje Koerner et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2007)
Visfatin promotes angiogenesis by activation of extracellular signal-regulated kinase 1/2
Su-Ryun Kim et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Crystallization of human nicotinamide phosphoribosyltransferase
Ryo Takahashi et al.
ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS (2007)
Extension of human cell lifespan by nicotinamide phosphoribosyltransferase
Eric van der Veer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
TNF-α alters visfatin and adiponectin levels in human fat
J. Hector et al.
HORMONE AND METABOLIC RESEARCH (2007)
Human visfatin expression: Relationship to insulin sensitivity, intramyocellular lipids, and inflammation
Vijayalakshmi Varma et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Insulin-like effects of visfatin on human osteoblasts
H. Xie et al.
CALCIFIED TISSUE INTERNATIONAL (2007)
Mechanisms linking obesity to insulin resistance and type 2 diabetes
Steven E. Kahn et al.
NATURE (2006)
Visfatin in adipocytes is upregulated by hypoxia through HIFIα-dependent mechanism
Katsumori Segawa et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Serum visfatin increases with progressive β-cell deterioration
Abel Lopez-Bermejo et al.
DIABETES (2006)
Crystal structure of visfatin/pre-B cell colony-enhancing factor 1/nicotinamide phosphoribosyltransferase, free and in complex with the anti-cancer agent FK-866
Mun-Kyoung Kim et al.
JOURNAL OF MOLECULAR BIOLOGY (2006)
The visfatin gene is associated with glucose and lipid metabolism in a Chinese population
W. -X. Jian et al.
DIABETIC MEDICINE (2006)
The release of the adipocytokine visfatin is regulated by glucose and insulin
D. G. Haider et al.
DIABETOLOGIA (2006)
Hypoxic induction of human visfatin gene is directly mediated by hypoxia-inducible factor-1
Soo-Kyung Bae et al.
FEBS LETTERS (2006)
Structure of Nampt/PBEF/visfatin, a mammalian NAD+ biosynthetic enzyme
Tao Wang et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2006)
Genetic variation in the visfatin gene (PBEF1) and its relation to glucose metabolism and fat-depot-specific messenger ribonucleic acid expression in humans
Yvonne Boettcher et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Regulation of pre-B cell colony-enhancing factor by STAT-3-dependent interleukin-6 trans-signaling -: Implications in the pathogenesis of rheumatoid arthritis
Mari A. Nowell et al.
ARTHRITIS AND RHEUMATISM (2006)
Molecular basis for the inhibition of human NMPRTase, a novel target for anticancer agents
Javed A. Khan et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2006)
Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding
DG Haider et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Macrophages in human visceral adipose tissue:: increased accumulation in obesity and a source of resistin and visfatin
CA Curat et al.
DIABETOLOGIA (2006)
Sirt1 regulates insulin secretion by repressing UCP2 in pancreatic β cells
L Bordone et al.
PLOS BIOLOGY (2006)
Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus
MP Chen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Poly(ADP-ribose) polymerase-1-dependent cardiac myocyte cell death during heart failure is mediated by NAD+ depletion and reduced Sir2α deacetylase activity
JB Pillai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Interleukin-6 is a negative regulator of visfatin gene expression in 3T3-L1 adipocytes
S Kralisch et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2005)
Hormonal regulation of the novel adipocytokine visfatin in 3T3-L1 adipocytes
S Kralisch et al.
JOURNAL OF ENDOCRINOLOGY (2005)
被撤回的出版物: Visfatin: A protein secreted by visceral fat that mimics the effects of insulin (Retracted article, see vol 318, pg 565, 2007)
A Fukuhara et al.
SCIENCE (2005)
The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells
JR Revollo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
FOXO4 is acetylated upon peroxide stress and deacetylated by the longevity protein hSir2SIRT1
A van der Horst et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Discoveries of nicotinamide riboside as a nutrient and conserved NRK genes establish a Preiss-Handler independent route to NAD+ in fungi and humans
P Bieganowski et al.
CELL (2004)
Growth phase-dependent changes in the subcellular localization of pre-B-cell colony-enhancing factor
T Kitani et al.
FEBS LETTERS (2003)
Inhibition of silencing and accelerated aging by nicotinamide, a putative negative regulator of yeast Sir2 and human SIRT1
KJ Bitterman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Pre-B-cell colony-enhancing factor, a novel cytokine of human fetal membranes
S Ognjanovic et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2002)
Is there an association between shift work and having a metabolic syndrome? Results from a population based study of 27,485 people
B Karlsson et al.
OCCUPATIONAL AND ENVIRONMENTAL MEDICINE (2001)
Identification of a plasmid-encoded gene from Haemophilus ducreyi which confers NAD independence
PR Martin et al.
JOURNAL OF BACTERIOLOGY (2001)
分享论文
